Fertility and Sterility
Volume 91, Issue 5 , Pages 1941-1944, May 2009

Advantage of conservative surgical management of large ovarian neoplasms in adolescents

  • Jhansi Reddy, M.D.
  • ,
  • Marc R. Laufer, M.D.

      Affiliations

    • Corresponding Author InformationCorrespondence to: Marc R. Laufer, M.D., Division of Gynecology, 300 Longwood Avenue, Boston, Massachusetts 02115 (FAX: 617-730-0186).

Division of Gynecology, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts

Received 29 December 2007; received in revised form 13 February 2008; accepted 13 February 2008. published online 14 April 2008.

Objective

To measure the postoperative size and volume of the ovary after cystectomy for a neoplasm ≥10 cm.

Design

Retrospective case series.

Setting

Academic medical center.

Patient(s)

Nine patients who underwent surgical management for an ovarian neoplasm at Children's Hospital Boston between November 2003 and November 2007.

Intervention(s)

Patients were evaluated by ultrasound postoperatively.

Main Outcome Measure(s)

Sonographic size and volume of the ovary after cystectomy for an ovarian neoplasm ≥10 cm.

Result(s)

The mean age of the patients was 14.2 ± 2.2 years, ranging between 10 and 17 years. The mean preoperative size of the ovarian neoplasm was 14.8 ± 3.8 cm, ranging between 10 and 20 cm. Serum tumor markers were negative in seven out of nine patients. There were no borderline tumors or malignancies identified. There was no statistically significant difference between the size or volume of the affected ovary and the contralateral ovary at the time of postoperative evaluation.

Conclusion(s)

Postoperative ultrasound revealed that the affected ovary resumed its normal size and volume despite the attenuated appearance of the ovarian cortex at the time of surgery. Ovarian cystectomy should be the preferred surgical approach for adolescents to ensure conservation of ovarian tissue.

Key Words: Adolescents, ovarian neoplasm, ovarian cyst, cystectomy, pelvic ultrasound, serum tumor markers

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 J.R. has nothing to disclose. M.R.L. has nothing to disclose.

 Presented in part at the Annual Clinical Meeting of the American Society for Reproductive Medicine, which was held in Washington, D.C., October 13–17, 2007.

PII: S0015-0282(08)00490-1

doi:10.1016/j.fertnstert.2008.02.116

Fertility and Sterility
Volume 91, Issue 5 , Pages 1941-1944, May 2009